Evidence map›Paper›PMID 27863012›Full record

ReviewThe FEBS journal2017

Maxed out macs: physiologic cell clearance as a function of macrophage phagocytic capacity.

Clive S Zent, Michael R Elliott

Abstract readReview
In one paragraph

Review in The FEBS journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Clive S ZentWilmot Cancer Institute, University of Rochester Medical Center, NY, USA.
Michael R ElliottDepartment of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, NY, USA.

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OLAF KUTSCH · 1988 to 2026
$84.1M
Immunoregulatory role of CD73 in efferocytosisR01AI114554 · NIAID · UNIVERSITY OF VIRGINIA · PI ELLIOTT, MICHAEL RUSTY · 2015 to 2019
$2.5M
NIAID NIH HHS P30 AI027767NIAID NIH HHS R01 AI114554
6 · The paper itself

Abstract

The phagocytic clearance of host cells is important for eliminating dying cells and for the therapeutic clearance of antibody-targeted cells. As ubiquitous, motile and highly phagocytic immune cells, macrophages are principal players in the phagocytic removal of host cells throughout the body. In recent years, great strides have been made in identifying the molecular mechanisms that control the recognition and phagocytosis of cells by macrophages. However, much less is known about the physical and metabolic constraints that govern the amount of cellular material macrophages can ingest and how these limitations affect the overall efficiency of host cell clearance in health and disease. In this review we will discuss, in the contexts of apoptotic cells and antibody-targeted malignant cells, how physical and metabolic factors associated with the internalization of host cells are relayed to the phagocytic machinery and how these signals can impact the overall efficiency of cell clearance. We also discuss how this information can be leveraged to increase cell clearance for beneficial therapeutic outcomes.

Indexed as

AnimalsAntibodies, MonoclonalApoptosisCoculture TechniquesDNA-Binding ProteinsGene Expression RegulationGTPase-Activating ProteinsHumansMacrophagesPhagocytosisPhospholipidsrac1 GTP-Binding ProteinReceptors, FcSignal TransductionTranscription FactorsTumor Cells, CulturedAntibodies, MonoclonalDNA-Binding ProteinsGTPase-Activating ProteinsPhospholipidsrac1 GTP-Binding ProteinRAC1 protein, humanReceptors, FcSLC2A4RG protein, humanTranscription Factorsapoptosiscellular metabolismchronic lymphocytic leukemiaefferocytosisGTPaselymphoid malignancymacrophagemonoclonal antibody therapyphagocytosis

Identifiers

PMID27863012
PMCPMC5378628

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.